Table 4 Pathological characteristics of patients with IgAN.
Confirmation cohort | Validation cohort | |
|---|---|---|
no. of subjects | 30 | 144 |
M0/M1 (n) | 18:12 | 77:67 |
E0/E1 (n) | 22:8 | 118:26 |
S0/S1 (n) | 9:21 | 24:120 |
T0/T1/T2 (n) | 18:12:0 | 92:46:6 |
C0/C1/C2 (n) | 25:5:0 | 88:56:0 |
Confirmation cohort | Validation cohort | |
|---|---|---|
no. of subjects | 30 | 144 |
M0/M1 (n) | 18:12 | 77:67 |
E0/E1 (n) | 22:8 | 118:26 |
S0/S1 (n) | 9:21 | 24:120 |
T0/T1/T2 (n) | 18:12:0 | 92:46:6 |
C0/C1/C2 (n) | 25:5:0 | 88:56:0 |